Companies: 10,795·Total market cap: $144.5T
Orgenesis Inc.

Orgenesis Inc.

ORGSOTCHealthcare● Active
$0.50
+$0.01(+1.02%)
Market Cap$2558779
P/E Ratio—
52W High$5.89
52W Low$0.02
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Orgenesis Inc. (ORGS) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ORGS · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-2.80orgs eps ttm · orgs earnings per shareEarnings history
PE Ratio (TTM)—orgs pe ratio ttm · orgs price to earningsPE Ratio deep dive
Revenue (TTM)$-12.9Morgs revenue ttm · orgs annual revenueFull revenue history
Dividend YieldNo Dividenddoes orgs pay dividends · orgs dividend yieldDividend history
Shares Outstanding29.0Morgs shares outstanding · orgs floatShares outstanding history
Next EarningsAug 7, 2026Est.orgs earnings date · orgs next earningsEarnings history

Explore Orgenesis Inc. Data

orgs stock data · financials
Market Cap$2.6Morgs market cap · orgs valuation
Analyst Forecast$— · Buy
DividendsNo Dividenddoes orgenesis inc. pay dividends · orgs dividend yield
Revenue$530000-98.53%orgenesis inc. annual revenue · orgs revenue
EarningsEPS $-1.91-223.73%orgs earnings · orgs eps
PE Ratio—orgs pe ratio · orgs price to earnings

Financial Snapshot

Full Financials
FY 2023Revenue$530000.00▼ 98.53% YoY
202120222023
orgenesis inc. revenue · orgs revenue 2023
FY 2023Net Income-$55.4M▼ 271.82% YoY
202120222023
orgenesis inc. net income · orgs profit 2023
FY 2023EPS$-1.91▼ 223.73% YoY
202120222023
orgs eps · orgenesis inc. earnings per share 2023
TTM:Revenue: -$12.9MNet Income: -$43.9MEPS: $-2.80View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy1 analystsis orgs a buy · orgs analyst rating
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$—Low
$0.49Current
$—Avg Target
$—High
orgs price target · orgs 12 month forecast

Total: 1 · Buy rate: 100.0%

Stock Performance

Full History
1D+1.02%
1W+1.02%
1M+41.43%
3M-10.81%
YTD+230.00%
1Y-78.19%
5Y-99.03%

About Orgenesis Inc.

CEOVered Caplan
IPO DateMar 13, 2012
Employees146
CountryUS
Websiteorgenesis.com

Orgenesis Inc. is a global biotechnology firm dedicated to the field of cell and gene therapies. The company has engineered an innovative Point of Care (POCare) platform. This system incorporates a po…

BiotechnologyHealthcareOTCUS

what is orgenesis inc. · orgs stock overview · orgenesis inc. company profile · who is orgenesis inc. ceo · orgs OTC · orgenesis inc. headquarters · orgenesis inc. business segments

About Stock Overview & Key Data

Orgenesis Inc. (ORGS) is a Healthcare company in the Biotechnology industry, listed on OTC since Mar 13, 2012. As of the latest trading session, ORGS stock price is $0.49, with a market capitalization of $2.6M. The stock has returned -78.19% over the past 12 months and +230.00% year-to-date.

According to 1 Wall Street analysts, the consensus rating for Orgenesis Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, Orgenesis Inc. reported revenue of $530000.00 and net income of -$55.4M. For detailed data — including Orgenesis Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Orgenesis Inc. (ORGS) stock price is $0.49. The stock is traded on OTC under the ticker symbol ORGS. The 52-week range is $0.02 – $5.89.

ORGS stock priceORGS quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice